Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026)
Cartesian Therapeutics (RNAC) posted quarterly Exchange Rate Effect of -$7000.0 for Q1 2026, down 121.88% year-over-year from $32000.0 in Q1 2025, and down 163.64% quarter-over-quarter from $11000.0 in Q4 2025.
Cartesian Therapeutics (RNAC) Exchange Rate Effect (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has reported Exchange Rate Effect for 12 consecutive years, with -$7000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 121.88% year-over-year to -$7000.0; the TTM figure through Mar 2026 stood at $6000.0 (down 62.5% YoY), while the FY2025 annual figure was $45000.0, up 314.29% from the prior year.
- Exchange Rate Effect eased to -$7000.0 in Q1 2026 per RNAC's latest filing, from $11000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $115000.0 in Q2 2022 and bottomed at -$45000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$941.18 across 5 years, with a median of -$10000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 650.0% — and 2025, when it surged 740.0%.
- Cartesian Therapeutics' Exchange Rate Effect stood at -$45000.0 in 2022, then surged by 135.56% to $16000.0 in 2023, then tumbled by 193.75% to -$15000.0 in 2024, then surged by 173.33% to $11000.0 in 2025, then sank by 163.64% to -$7000.0 in 2026.
- Business Quant data shows RNAC's Exchange Rate Effect at -$7000.0 in Q1 2026, $11000.0 in Q4 2025, and -$10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Cartesian Therapeutics | 265.54 Mn | 265.54 Mn | - | -25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25,000.00 |
| Jun 30, 2026 | -25,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Sep 30, 2025 | -10,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Dec 31, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |